Clinical Trial Update: Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for radioimmunotherapy in patients with relapsed or refractory non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Lymphoma | Phase 2 | Status: COMPLETED